Chinese Pharmaceuticals & Biotech Upcoming Dividends

Getein Biotech

Market Cap: CN¥4.2b

Researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally.

Sichuan Goldstone Asia Pharmaceutical

Market Cap: CN¥3.7b

Sichuan Goldstone Asia Pharmaceutical Inc.

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥34.1b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

Beijing Aosaikang Pharmaceutical

Market Cap: CN¥11.9b

Beijing Aosaikang Pharmaceutical Co., Ltd.

China Resources Jiangzhong PharmaceuticalLtd

Market Cap: CN¥15.3b

Engages in the manufacture of pharmaceutical products in China.

Anhui Fengyuan Pharmaceutical

Market Cap: CN¥2.5b

Researches and develops, produces, and sells medicines in China.

Tibet Cheezheng Tibetan Medicine

Market Cap: CN¥11.6b

Tibet Cheezheng Tibetan Medicine Co., Ltd.

Shenzhen Hepalink Pharmaceutical Group

Market Cap: CN¥12.1b

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Northeast Pharmaceutical Group

Market Cap: CN¥6.4b

Engages in chemical pharmaceuticals manufacturing, pharmaceutical distribution, pharmaceutical engineering, biopharmaceuticals, and other businesses in China.

Shanghai Shenqi Pharmaceutical Investment Management

Market Cap: CN¥2.5b

Operates as a pharmaceutical manufacturing holding investment company in China.

Teyi Pharmaceutical GroupLtd

Market Cap: CN¥4.1b

Engages in the research and development, production, and sale of Chinese patented medicines, pharmaceutical preparations, raw materials, and products in the People’s Republic of China.

Zhejiang AngLiKang PharmaceuticalLTD

Market Cap: CN¥5.5b

A pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases.